Casey Johnson

2.3k total citations
19 papers, 1.8k citations indexed

About

Casey Johnson is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Casey Johnson has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Casey Johnson's work include Respiratory viral infections research (10 papers), Influenza Virus Research Studies (9 papers) and Immune Response and Inflammation (6 papers). Casey Johnson is often cited by papers focused on Respiratory viral infections research (10 papers), Influenza Virus Research Studies (9 papers) and Immune Response and Inflammation (6 papers). Casey Johnson collaborates with scholars based in United States, Germany and Belgium. Casey Johnson's co-authors include Lynda Tussey, Uma Kavita, David N. Taylor, Alan Shaw, Thomas P. Monath, Donald M. Poretz, Les Huson, Robert L. Atmar, Penelope Ward and M. Schilling and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Casey Johnson

19 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Casey Johnson United States	15	947	747	590	484	273	19	1.8k
Philippe Moris Belgium	30	1.3k 1.4×	918 1.2×	546 0.9×	1.4k 2.8×	653 2.4×	54	2.8k
Kai Schulze Germany	29	432 0.5×	553 0.7×	322 0.5×	781 1.6×	567 2.1×	71	1.9k
Gregg N. Milligan United States	30	1.2k 1.3×	722 1.0×	465 0.8×	931 1.9×	169 0.6×	72	2.3k
Christine S. Rollier United Kingdom	22	704 0.7×	545 0.7×	214 0.4×	526 1.1×	347 1.3×	65	1.7k
Angelika Banzhoff Germany	25	1.2k 1.3×	685 0.9×	339 0.6×	509 1.1×	311 1.1×	64	2.0k
Alexandra J. Spencer United Kingdom	21	700 0.7×	860 1.2×	323 0.5×	606 1.3×	442 1.6×	53	1.9k
Frank Follmann Denmark	25	974 1.0×	688 0.9×	120 0.2×	939 1.9×	487 1.8×	49	2.2k
Astrid Borkowski Switzerland	27	1.5k 1.5×	1.3k 1.8×	397 0.7×	616 1.3×	237 0.9×	50	2.7k
Kobporn Boonnak Thailand	18	975 1.0×	928 1.2×	483 0.8×	324 0.7×	229 0.8×	53	1.8k
Benjamin Wizel United States	25	816 0.9×	496 0.7×	549 0.9×	876 1.8×	358 1.3×	41	1.8k

Countries citing papers authored by Casey Johnson

Since Specialization

Citations

This map shows the geographic impact of Casey Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casey Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casey Johnson more than expected).

Fields of papers citing papers by Casey Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casey Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casey Johnson. The network helps show where Casey Johnson may publish in the future.

Co-authorship network of co-authors of Casey Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Casey Johnson. A scholar is included among the top collaborators of Casey Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Casey Johnson. Casey Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Schwarz, Tino F., Casey Johnson, Dan Apter, et al.. (2021). Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women. The Journal of Infectious Diseases. 225(12). 2067–2076. 29 indexed citations

Turner, M., Peter Winkle, Nathan Segall, et al.. (2020). Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial. Human Vaccines & Immunotherapeutics. 16(10). 2456–2464. 24 indexed citations

Beran, Jiřı́, Geert Leroux‐Roels, Pierre Van Damme, et al.. (2020). Safety and immunogenicity of fully liquid and lyophilized formulations of an investigational trivalent group B streptococcus vaccine in healthy non-pregnant women: Results from a randomized comparative phase II trial. Vaccine. 38(16). 3227–3234. 8 indexed citations

Schwarz, Tino F., Casey Johnson, Dan Apter, et al.. (2020). 1239. Different Dose Levels of a Respiratory Syncytial Virus Maternal Vaccine Candidate (RSVPreF3) Administered to Non-pregnant Women in a Randomized Clinical Trial Are Immunogenic and Well Tolerated. Open Forum Infectious Diseases. 7(Supplement_1). S638–S639. 1 indexed citations

Beran, Jiřı́, Jason D. Lickliter, Tino F. Schwarz, et al.. (2018). Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials. The Journal of Infectious Diseases. 217(10). 1616–1625. 35 indexed citations

Tussey, Lynda, Cynthia Strout, Matthew Davis, et al.. (2016). Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins. Open Forum Infectious Diseases. 3(1). ofw015–ofw015. 31 indexed citations

Johnson, Casey, et al.. (2014). Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer-Blind, Dose-Ranging Study. The Journal of Infectious Diseases. 212(1). 72–80. 6 indexed citations

Taylor, David N., John J. Treanor, Eric Sheldon, et al.. (2012). Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response. Vaccine. 30(39). 5761–5769. 102 indexed citations

Monath, Thomas P., Elizabeth Fowler, Casey Johnson, et al.. (2011). An Inactivated Cell-Culture Vaccine against Yellow Fever. New England Journal of Medicine. 364(14). 1326–1333. 84 indexed citations

10.

Stanberry, Lawrence R., Jakub K. Simon, Casey Johnson, et al.. (2011). Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens. Vaccine. 30(2). 307–316. 53 indexed citations

11.

Taylor, David N., John J. Treanor, Cynthia Strout, et al.. (2011). Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI). Vaccine. 29(31). 4897–4902. 132 indexed citations

12.

Turley, Christine B., Richard Rupp, Casey Johnson, et al.. (2011). Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine. 29(32). 5145–5152. 249 indexed citations

13.

Talbot, H. Keipp, Michael T. Rock, Casey Johnson, et al.. (2010). Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin. PLoS ONE. 5(12). e14442–e14442. 68 indexed citations

14.

Langley, Joanne M., Louise Frenette, Linda Ferguson, et al.. (2010). Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults. The Journal of Infectious Diseases. 201(11). 1644–1653. 76 indexed citations

15.

Monath, Thomas P., Niranjan Kanesa-thasan, Gwendolyn A. Myers, et al.. (2006). A live, attenuated recombinant West Nile virus vaccine. Proceedings of the National Academy of Sciences. 103(17). 6694–6699. 155 indexed citations

16.

Johnson, Casey, Thomas P. Monath, Niranjan Kanesa-thasan, et al.. (2005). Exercise-Induced Serum Enzyme Elevations Confounding the Evaluation of Investigational Drug Toxicity: Report of Two Cases in a Vaccine Trial. Human Vaccines. 1(1). 24–29. 7 indexed citations

17.

Monath, Thomas P., Farshad Guirakhoo, Richard Nichols, et al.. (2003). Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen. The Journal of Infectious Diseases. 188(8). 1213–1230. 165 indexed citations

18.

Monath, Thomas P., Karen McCarthy, Philip Bedford, et al.. (2002). Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections. Vaccine. 20(7-8). 1004–1018. 164 indexed citations

19.

Hayden, Frederick G., Robert L. Atmar, M. Schilling, et al.. (1999). Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza. New England Journal of Medicine. 341(18). 1336–1343. 384 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact